Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis. (Q43172181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dana Michalská

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

D B Burr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Y L Ma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Petto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Sipos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Dobnig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Fahrleitner-Pammer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

I Pavo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

5 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

2027-2036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

Maintaining low concentrations of plasma beta 2-microglobulin through continuous slow haemofiltration

17 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-009-1168-7

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Vertebral fractures in osteoporosis: a new method for clinical assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Alendronate inhibits PTH (1-34)-induced bone morphogenetic protein expression in MC3T3-E1 preosteoblastic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Mechanisms of anabolic therapies for osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135094

12 December 2020

10.1007/S00198-009-1168-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20135094%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 January 2020

1004971319

0 references

1 reference